TQB2868
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TQB2868, covering 2024-06-21 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms [Phase 2]